ISRCTN ISRCTN65705512
DOI https://doi.org/10.1186/ISRCTN65705512
Secondary identifying numbers 12683
Submission date
25/07/2012
Registration date
26/07/2012
Last edited
04/03/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Dr Deborah Lycett
Scientific

Primary Care Clinical Sciences School of Health and Population Sciences, Edgbaston
Birmingham
B15 2TT
United Kingdom

Study information

Study designRandomised interventional phase II trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typePrevention
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleSlimming World in Stop Smoking Services (SWISSS)
Study acronymSWISSS
Study hypothesisQuitting smokers gain weight which puts some off attempting to quit, and seems to increase the risk of developing type 2 diabetes. Dieting is the main way to control weight but may worsen cigarette cravings and undermine cessation. A review of trials showed general healthy eating education does not reduce weight gain in quitting smokers and may hamper smoking cessation. However, planning diets to meet individual requirements, setting and reviewing weight targets does reduce weight gain; but whether this reduces the chance of successfully quitting is uncertain.

Commercial weight management programmes (CWMPs) provide this type of individual dietary support and are available on prescription in most primary care trusts. Clinical trials show CWMPs lead to greater weight loss than other primary care interventions or dieting without support. The aim of this trial is to assess whether referral to a CWMP reduces weight gain on smoking cessation. If so, this would lead to a necessary much larger trial to see whether it did so at the expense of successfully quitting smoking.

We will recruit patients from NHS stop smoking services, they must be smokers over 18 without any condition in which weight loss would be harmful. They will be randomised to either a CWMP during their quit attempt or usual care. All will receive usual stop smoking support and be weighed at the start, end of treatment and at six month follow-up.
Ethics approval(s)First MREC, 29 June 2012 ref:12/SW/0159
ConditionSmoking and weight loss
InterventionThis will be the withdrawal orientated behavioural support provided by NHS stop smoking services which increase the chance of a successful quit attempt four-fold (West, 2010). This consists of weekly behavioural support typically for two weeks before and until four weeks after quit day focusing on key behavioural change techniques and nicotine replacement, varenicline, or bupropion are given to relieve withdrawal symptoms. Participants are encouraged to quit smoking first, before tackling weight; Usual care plus Slimming World, In addition to usual care, participants will be given a referral voucher for Slimming World when they attend their pre-quit visit. They will be booked in to attend weight management sessions from their quit day (or as near to that date as possible). They will attend SW for 12 weeks receiving support to lose or prevent weight gain. The choice of modest weight loss or weight gain prevention will depend upon whether an individual wants to lose weight or not and whether or not s/he is overweight or ; Follow Up Length: 5 month(s); Study Entry : Single Randomisation only
Intervention typeOther
Primary outcome measureChange in weight from baseline (one week before quit date) to twelve weeks
Secondary outcome measuresNo secondary outcome measures
Overall study start date24/09/2012
Overall study end date06/05/2013

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsUK Sample Size: 320; Description: We will recruit 320 participants, 160 in each arm. With an alpha error rate of 5% and 90% power this will detect a 2kg (SD=2.5)
Total final enrolment76
Participant inclusion criteria1. Daily smokers with expired CO >10ppm
2. Aged 18 or over
3. Willing to be randomised to either the control or intervention arm and willing and able to comply with the intervention and all study procedures
4. Male & female participants
Participant exclusion criteria1. Pregnant smokers
2. BMI<23 kg/m2. Mortality has been shown to be lowest in those with a 22>BMI<25 (Prospective studies collaboration, 2009) so preventing weight gain in those with lower BMIs is may not lead to health gain
3. Any medical condition in which weight loss would be contraindicated e.g. current course of chemotherapy
Recruitment start date24/09/2012
Recruitment end date06/05/2013

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Primary Care Clinical Sciences School of Health and Population Sciences, Edgbaston
Birmingham
B15 2TT
United Kingdom

Sponsor information

University of Birmingham (UK)
University/education

Behavioural Brain Sciences Centre
Edgbaston
Birmingham
B15 2TT
England
United Kingdom

Website http://www.birmingham.ac.uk/
ROR logo "ROR" https://ror.org/03angcq70

Funders

Funder type

Government

National Institute of Health Research [NIHR] - National School for Primary Care Research (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 19/06/2013 Yes No
Results article results 26/01/2020 04/03/2021 Yes No

Editorial Notes

04/03/2021: Publication reference and total final enrolment added.
26/09/2018: No publications found, verifying study status with principal investigator.